Data search
Results for MligTC455_44391
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_44391 | 2139 | 44.56 | Mlig455_034381, Mlig455_043867 | Neo: - Age: logFC(26M/2M)=1.551 Region-specific R2: 4.290 Region-enriched R2: 4.082/0.00000 |
Mlig455_034381 {REF} {Length: 1311} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=67.8, Expect=7e-14]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=1e-05]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} Mlig455_043867 {REF} {Length: 1251} {Pfam: Anemonia sulcata toxin III family [PF08098.13, score=19.1]} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=67.4, Expect=5e-14]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=1e-05]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} |
Cumulative graph for MligTC455_44391
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 0.081 | 5.611 | 0.93598 | 1.00000 | |
| RegionR2 | 4.082 | 5.611 | 0.00000 | 0.00000 | Specific for R2: 4.290 |
| RegionR3 | 2.984 | 5.611 | 0.00000 | 0.00000 | |
| RegionR4 | -0.288 | 5.611 | 0.69601 | 0.98615 | |
| RegionR5 | -0.081 | 5.611 | 0.90758 | 1.00000 | |
| RegionR6 | -0.498 | 5.611 | 0.45727 | 1.00000 | |
| RegionR7 | -3.949 | 5.611 | 0.00014 | 0.00757 | |
| RegionR8 | -2.33 | 5.611 | 0.02547 | 0.31085 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 1.412 | 5.611 | 0.23224 | 0.96191 | |
| RegenerationR2 | -1.066 | 5.611 | 0.12436 | 0.54606 | |
| RegenerationR3 | -0.584 | 5.611 | 0.40428 | 0.80557 | |
| RegenerationR4 | 0.033 | 5.611 | 0.96261 | 1.00000 | |
| RegenerationR5 | -0.497 | 5.611 | 0.49491 | 0.85589 | |
| RegenerationR6 | -0.048 | 5.611 | 0.95003 | 1.00000 | |
| RegenerationBL | 1.656 | 5.611 | 0.04337 | 0.23756 | |
| RegenerationTP | 2.235 | 5.611 | 0.02742 | 0.27904 |
Genes with expression patterns similar to MligTC455_44391
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_44391 | 2139 | 44.56 | Mlig455_034381, Mlig455_043867 | Neo: - Age: logFC(26M/2M)=1.551 Region-specific R2: 4.290 Region-enriched R2: 4.082/0.00000 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_034381 {REF} {Length: 1311} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=67.8, Expect=7e-14]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=1e-05]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} Mlig455_043867 {REF} {Length: 1251} {Pfam: Anemonia sulcata toxin III family [PF08098.13, score=19.1]} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=67.4, Expect=5e-14]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=1e-05]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} |
|
| 2. | MligTC455_44390 | 1061 | 22.1 | Mlig455_034325 | Neo: - Age: - Region-specific R2: 4.305 Region-enriched R2: 4.226/0.00000 |
5.997 | 0.997 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_034325 {REF} {Length: 1082} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=65.1, Expect=2e-13]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=9e-06]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} | |
| 3. | MligTC455_44050 | 2086 | 43.46 | Mlig455_028045, Mlig455_028051 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.242 Region-specific R2: 6.161 Region-enriched R2: 7.072/0.00000 |
4.285 | 0.875 | 0.858 | 0.768 | 0.964 | 0.820 | - | Mlig455_028045 {REF} {Length: 1156} {RNA1509_31459, RNA1509_3903} {RNA1310_2730.2, RNA1509_31459, RNA1509_3903} {RNA1509_31459, RNA1509_3903, RNA815_7682} Mlig455_028051 {REF} {Length: 871} {NoTransDecoderORF} {RNA1509_3903} {RNA1310_15260} {RNA815_7682} |
|
| 4. | MligTC455_50347 | 549 | 11.43 | Mlig455_012382 | Neo: - Age: Down-Up-Up Region-specific R2: 6.390 Region-enriched R2: 6.623/0.00000 |
4.274 | 0.873 | 0.782 | 0.769 | 0.959 | 0.891 | - | Mlig455_012382 {REF} {Length: 797} {RNA1509_48155} {RNA1310_70969.2, RNA1509_48155} {RNA1509_48155, RNA815_39712} | |
| 5. | MligTC455_18847 | 5039 | 104.98 | Mlig455_017924 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.933 Region-specific R3: 4.309 Region-enriched R3: 3.414/0.00000 |
3.394 | - | 0.829 | - | 0.966 | 0.762 | 0.837 | Mlig455_017924 {REF} {Length: 1071} {RNA1509_16771, RNA1509_3550} {RNA1310_54908.2, RNA1509_16771, RNA1509_3550} {RNA1509_16771, RNA1509_3550, RNA815_21198.1} | |
| 6. | MligTC455_11473 | 248 | 5.17 | Mlig455_009711, Mlig455_071036 | Neo: - Age: Down-Up-Down |
CHRNA3 | 3.379 | - | 0.762 | 0.776 | 0.982 | 0.859 | - | Mlig455_009711 {REF} {Length: 2402} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=241.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=391, Expect=2e-130]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=379, Expect=6e-126]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=375, Expect=2e-124]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=390, Expect=2e-130]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=375, Expect=2e-124]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [RH, Score=499, Expect=9e-173]} {Celegans: WBGene00000043, acr-3, Acetylcholine receptor subunit beta-type acr-3, [RH, Score=426, Expect=6e-145]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=510, Expect=1e-176]} {RNA1509_48201} {RNA1310_10118} {RNA815_29940} Mlig455_071036 {REF} {Length: 746} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.1]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=63.5, Expect=2e-13]} {Celegans: WBGene00000042, acr-2, Acetylcholine receptor subunit beta-type acr-2, [Score=63.9, Expect=9e-14]} {Smed: dd_Smed_v6_12535_0_1, dd_Smed_v6_12535_0_1, [Score=64.3, Expect=6e-14]} {RNA1310_21182} {RNA815_29940} |
| 7. | MligTC455_24756 | 12400 | 258.33 | Mlig455_017088 | Neo: - Age: Up-Down-Down Region-specific R2: 1.814 Region-enriched R2: 1.884/0.00008 |
SSPO | 2.692 | 0.824 | - | - | 0.957 | - | 0.911 | Mlig455_017088 {REF} {Length: 17786} {Pfam: von Willebrand factor type D domain [PF00094.27, score=205.1]; Spondin-like TSP1 domain [PF19028.2, score=137.7]; C8 domain [PF08742.13, score=88.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=71.6]; Thrombospondin type 1 domain [PF00090.21, score=65.8]; Low-density lipoprotein receptor domain class A [PF00057.20, score=57.2]} {Human: ENSG00000197558, SSPO, SCO-spondin, [RH, Score=577, Expect=8e-164]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=512, Expect=2e-144]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=335, Expect=6e-91]} {Celegans: WBGene00003072, lrp-2, Low-density lipoprotein RecePtor related, [Score=127, Expect=2e-28]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [RH, Score=1241, Expect=0.0]} {RNA1509_1916, RNA1509_4948} {RNA1310_608, RNA1509_4948} {RNA1509_4948, RNA815_152.1} |
| 8. | MligTC455_34693 | 336 | 7 | Mlig455_017459 | Neo: - Age: - Region-enriched R2: 6.024/0.00000 |
FZD4 | 2.602 | 0.704 | - | - | - | 0.926 | 0.972 | Mlig455_017459 {REF} {Length: 3882} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=335.8]; Fz domain [PF01392.24, score=90.0]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=424, Expect=3e-141]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=423, Expect=3e-141]} {Dmel: FBgn0001085, fz, frizzled, [Score=306, Expect=2e-95]} {Celegans: WBGene00003006, lin-17, Transmembrane receptor LIN-17, [RH, Score=271, Expect=1e-82]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=473, Expect=3e-160]} {RNA1509_10294} {RNA1310_2672} {RNA815_3209} |
| 9. | MligTC455_18122 | 1083 | 22.57 | Mlig455_020157 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.614 Region-specific R2: 4.994 Region-enriched R2: 4.087/0.00011 |
2.554 | - | - | 0.748 | 0.969 | 0.837 | - | Mlig455_020157 {REF} {Length: 2290} {RNA1310_56029} {RNA815_34539} | |
| 10. | MligTC455_29622 | 818 | 17.05 | Mlig455_047251, Mlig455_047304 | Neo: - Age: - Region-enriched R2: 2.325/0.00092 Regeneration-downregulated BL: -4.291 Regeneration-depleted BL: -4.291 |
CALM2 | 2.537 | - | - | - | 0.959 | 0.850 | 0.728 | Mlig455_047251 {REF} {Length: 2133} {Pfam: EF hand [PF00036.34, score=100.9]; EF-hand domain pair [PF13499.8, score=97.6]; EF-hand domain [PF13405.8, score=82.7]; EF-hand domain pair [PF13833.8, score=77.3]; EF hand [PF13202.8, score=73.6]; EF-hand domain [PF14658.8, score=41.0]; Dockerin type I domain [PF00404.20, score=35.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=29.7]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=26.5]; Tellurite resistance protein TerB [PF05099.15, score=20.5]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=127, Expect=3e-36]; ENSG00000198668, CALM1, calmodulin 1, [Score=125, Expect=6e-36]; ENSG00000160014, CALM3, calmodulin 3, [Score=125, Expect=7e-36]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=130, Expect=2e-37]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=125, Expect=5e-36]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=125, Expect=5e-36]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=122, Expect=4e-35]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=122, Expect=3e-35]} {Smed: dd_Smed_v6_12048_0_1, dd_Smed_v6_12048_0_1, [RH, Score=166, Expect=8e-50]} {RNA1509_29426} {RNA1310_21067.1} {RNA815_25363} Mlig455_047304 {REF} {Length: 1449} {Pfam: EF hand [PF00036.34, score=101.1]; EF-hand domain pair [PF13499.8, score=95.2]; EF-hand domain pair [PF13833.8, score=81.2]; EF-hand domain [PF13405.8, score=80.9]; EF hand [PF13202.8, score=73.1]; EF-hand domain [PF14658.8, score=40.8]; Dockerin type I domain [PF00404.20, score=34.9]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=30.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.0]; Tellurite resistance protein TerB [PF05099.15, score=20.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=125, Expect=2e-35]; ENSG00000198668, CALM1, calmodulin 1, [Score=124, Expect=4e-35]; ENSG00000160014, CALM3, calmodulin 3, [Score=123, Expect=4e-35]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=127, Expect=3e-36]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=123, Expect=3e-35]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=123, Expect=3e-35]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=120, Expect=2e-34]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=120, Expect=2e-34]} {Smed: dd_Smed_v6_12048_0_1, dd_Smed_v6_12048_0_1, [RH, Score=162, Expect=6e-48]} {RNA1509_29426} {RNA1310_20874} {RNA815_31458} |
| 11. | MligTC455_50187 | 2820 | 58.75 | Mlig455_035036, Mlig455_035044, Mlig455_053431 | Neo: - Age: Down-Up-Up Region-enriched R2: 1.537/0.02142 |
2.381 | - | - | 0.704 | 0.960 | 0.717 | - | Mlig455_035036 {REF} {Length: 1305} {RNA1509_11407} {RNA1310_23918.1} {RNA815_10516} Mlig455_035044 {REF} {Length: 1542} {RNA1509_11407, RNA1509_31858} {RNA1310_23918.1, RNA1509_11407, RNA1509_31858} {RNA1509_11407, RNA1509_31858, RNA815_10516} Mlig455_053431 {REF} {Length: 1057} {RNA1509_22090} {RNA1310_23918.1, RNA1509_22090} {RNA1509_22090, RNA815_10516} |
|
| 12. | MligTC455_26710 | 57107 | 1189.73 | Mlig455_000780, Mlig455_000781 | Neo: - Age: logFC(26M/2M)=-0.460 Region-enriched R2: 4.248/0.00001 |
1.819 | - | 0.847 | - | 0.972 | - | - | Mlig455_000780 {REF} {Length: 574} {RNA1509_267} {RNA1310_112043} {RNA815_7257.1} Mlig455_000781 {REF} {Length: 649} {RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785} {RNA1310_112043, RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785} {RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785, RNA815_7257.1} |
|
| 13. | MligTC455_47480 | 197 | 4.11 | Mlig455_025126 | Neo: - Age: - Region-enriched R2: 4.426/0.00106 |
1.784 | - | - | - | - | 0.828 | 0.956 | Mlig455_025126 {REF} {Length: 2071} {RNA1310_46346} {RNA815_22558.1} | |
| 14. | MligTC455_50734 | 175 | 3.66 | Mlig455_044294 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.054/0.00263 |
CHRNA3 | 1.758 | - | - | - | - | 0.805 | 0.953 | Mlig455_044294 {REF} {Length: 1830} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=242.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.5]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=373, Expect=1e-123]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=365, Expect=1e-120]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=360, Expect=9e-119]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=358, Expect=6e-118]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=376, Expect=3e-125]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=374, Expect=4e-124]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=450, Expect=4e-154]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [RH, Score=651, Expect=0.0]} {RNA1509_45903} {RNA1310_14580} {RNA815_10044.1} |
| 15. | MligTC455_51161 | 167 | 3.48 | Mlig455_054766, Mlig455_054793, Mlig455_054886 | Neo: - Age: - |
PCDH11Y | 1.747 | - | - | - | - | 0.766 | 0.981 | Mlig455_054766 {REF} {Length: 3637} {Pfam: Cadherin domain [PF00028.19, score=201.7]; Cadherin-like [PF08266.14, score=34.1]} {Human: ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=257, Expect=7e-70]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=254, Expect=4e-69]; ENSG00000184226, PCDH9, protocadherin 9, [Score=253, Expect=5e-69]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=258, Expect=1e-70]; ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=249, Expect=9e-68]} {Dmel: FBgn0001075, ft, fat, [Score=209, Expect=2e-54]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=163, Expect=2e-40]} {Smed: dd_Smed_v6_10467_0_1, dd_Smed_v6_10467_0_1, [RH, Score=300, Expect=1e-85]} {RNA1509_42466} {RNA1310_4089.1} {RNA815_19162} Mlig455_054793 {REF} {Length: 3680} {Pfam: Cadherin domain [PF00028.19, score=202.3]; Cadherin-like [PF08266.14, score=33.5]} {Human: ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=252, Expect=3e-68]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=250, Expect=2e-67]; ENSG00000184226, PCDH9, protocadherin 9, [Score=249, Expect=7e-68]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=255, Expect=2e-69]; ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=246, Expect=2e-66]} {Dmel: FBgn0001075, ft, fat, [Score=203, Expect=1e-52]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=159, Expect=4e-39]} {Smed: dd_Smed_v6_10467_0_1, dd_Smed_v6_10467_0_1, [RH, Score=301, Expect=6e-86]} {RNA1509_42466} {RNA1310_4089.1, RNA1509_42466} {RNA1509_42466, RNA815_15304} Mlig455_054886 {REF} {Length: 3606} {Pfam: Cadherin domain [PF00028.19, score=202.1]; Cadherin-like [PF08266.14, score=33.5]} {Human: ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=251, Expect=1e-67]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=249, Expect=4e-67]; ENSG00000184226, PCDH9, protocadherin 9, [Score=248, Expect=5e-67]; ENSG00000156453, PCDH1, protocadherin 1, [Score=239, Expect=5e-64]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=255, Expect=3e-69]; ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=243, Expect=9e-66]} {Dmel: FBgn0001075, ft, fat, [Score=204, Expect=1e-52]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=159, Expect=5e-39]} {Smed: dd_Smed_v6_10467_0_1, dd_Smed_v6_10467_0_1, [RH, Score=300, Expect=1e-85]} {RNA1509_42466} {RNA1310_4089.1} {RNA815_15304} |
| 16. | MligTC455_40648 | 60 | 1.24 | Mlig455_034479 | Neo: - Age: Down-Up-Up |
1.736 | - | - | - | - | 0.782 | 0.954 | Mlig455_034479 {REF} {Length: 2499} {RNA1310_42980.1} {RNA815_47590} | |
| 17. | MligTC455_45978 | 405 | 8.44 | Mlig455_023485, Mlig455_068113 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.653 Region-enriched R2: 2.082/0.02665 |
MUC4, VWDE | 0.975 | - | - | - | - | - | 0.975 | Mlig455_023485 {REF} {Length: 6294} {Pfam: Calcium-binding EGF domain [PF07645.17, score=93.2]; EGF-like domain [PF00008.29, score=73.5]; EGF domain [PF12947.9, score=64.1]; Complement Clr-like EGF-like [PF12662.9, score=58.9]; von Willebrand factor type D domain [PF00094.27, score=57.2]; Coagulation Factor Xa inhibitory site [PF14670.8, score=39.7]; Human growth factor-like EGF [PF12661.9, score=36.7]; Nidogen-like [PF06119.16, score=25.0]} {Human: ENSG00000277585, MUC4, mucin 4, cell surface associated, [RH, Score=131, Expect=6e-30]; ENSG00000145113, MUC4, mucin 4, cell surface associated, [RH, Score=130, Expect=6e-30]; ENSG00000273984, MUC4, mucin 4, cell surface associated, [RH, Score=130, Expect=1e-29]; ENSG00000276613, MUC4, mucin 4, cell surface associated, [RH, Score=130, Expect=8e-30]; ENSG00000278303, MUC4, mucin 4, cell surface associated, [RH, Score=130, Expect=8e-30]; ENSG00000273822, MUC4, mucin 4, cell surface associated, [RH, Score=130, Expect=8e-30]; ENSG00000278468, MUC4, mucin 4, cell surface associated, [RH, Score=129, Expect=2e-29]} {Mouse: ENSMUSG00000026923, Notch1, notch 1, [Score=109, Expect=2e-23]; ENSMUSG00000063681, Crb1, crumbs family member 1, photoreceptor morphogenesis associated, [Score=108, Expect=5e-23]; ENSMUSG00000028369, Svep1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=108, Expect=7e-23]; ENSMUSG00000027878, Notch2, notch 2, [Score=108, Expect=6e-23]; ENSMUSG00000038146, Notch3, notch 3, [Score=107, Expect=1e-22]; ENSMUSG00000035403, Crb2, crumbs family member 2, [Score=106, Expect=2e-22]; ENSMUSG00000079620, Muc4, mucin 4, [Score=105, Expect=4e-22]} {Dmel: FBgn0031879, uif, uninflatable, [Score=101, Expect=4e-21]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=95.9, Expect=2e-19]} {Smed: dd_Smed_v6_7067_0_1, dd_Smed_v6_7067_0_1, [Score=97.1, Expect=6e-20]} {RNA1509_17981, RNA1509_2949} {RNA1310_1028.1, RNA1509_17981, RNA1509_2949} {RNA1509_17981, RNA1509_2949, RNA815_327.1} Mlig455_068113 {REF} {Length: 2133} {Pfam: EGF-like domain [PF00008.29, score=61.1]; EGF domain [PF12947.9, score=52.4]; Human growth factor-like EGF [PF12661.9, score=46.5]; Calcium-binding EGF domain [PF07645.17, score=45.3]; CDK5 regulatory subunit-associated protein 3 [PF05600.14, score=22.5]; Complement Clr-like EGF-like [PF12662.9, score=22.4]; Coagulation Factor Xa inhibitory site [PF14670.8, score=21.5]} {Human: ENSG00000146530, VWDE, von Willebrand factor D and EGF domains, [RH, Score=110, Expect=7e-26]} {Mouse: ENSMUSG00000026923, Notch1, notch 1, [Score=111, Expect=1e-26]; ENSMUSG00000028369, Svep1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=108, Expect=2e-25]; ENSMUSG00000038146, Notch3, notch 3, [Score=108, Expect=2e-25]; ENSMUSG00000027878, Notch2, notch 2, [Score=107, Expect=3e-25]} {Dmel: FBgn0004647, N, Notch, [Score=102, Expect=2e-23]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=94.7, Expect=4e-21]} {Smed: dd_Smed_v6_7067_0_1, dd_Smed_v6_7067_0_1, [Score=98.6, Expect=2e-22]} {RNA1509_2949} {RNA1310_1028.1} {RNA815_327.1} |
| 18. | MligTC455_48667 | 50 | 1.04 | Mlig455_068928 | Neo: - Age: - Region-enriched R7: 5.208/0.00414 |
0.975 | - | - | - | - | - | 0.975 | Mlig455_068928 {REF} {Length: 352} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_84084} {RNA815_60984} | |
| 19. | MligTC455_23142 | 769 | 16.02 | Mlig455_008044 | Neo: - Age: - |
INSR | 0.973 | - | - | - | 0.973 | - | - | Mlig455_008044 {REF} {Length: 5353} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=291.8]; Protein kinase domain [PF00069.27, score=128.4]; Receptor L domain [PF01030.26, score=118.4]; Furin-like cysteine rich region [PF00757.22, score=79.0]; Fibronectin type III domain [PF00041.23, score=45.0]; Growth factor receptor domain IV [PF14843.8, score=19.9]} {Human: ENSG00000171105, INSR, insulin receptor, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000005534, Insr, insulin receptor, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0283499, InR, Insulin-like receptor, [RH, Score=333, Expect=8e-93]} {Celegans: WBGene00000898, daf-2, Insulin-like receptor Insulin-like receptor subunit alpha Insulin-like receptor subunit beta, [RH, Score=474, Expect=3e-140]} {Smed: dd_Smed_v6_9006_0_1, dd_Smed_v6_9006_0_1, [RH, Score=514, Expect=3e-157]} {RNA1509_5152} {RNA1310_762.1} {RNA815_285.1} |
| 20. | MligTC455_23548 | 13 | 0.28 | Mlig455_029881 | Neo: - Age: - |
0.969 | - | - | - | - | - | 0.969 | Mlig455_029881 {REF} {Length: 2293} {RNA1310_58945} {RNA815_43403} | |
| 21. | MligTC455_25200 | 17 | 0.36 | Mlig455_054567 | Neo: - Age: - |
0.959 | - | - | - | - | - | 0.959 | Mlig455_054567 {REF} {Length: 992} {NoTransDecoderORF} {RNA1509_11398} {RNA1310_877.1} {RNA815_745} | |
| 22. | MligTC455_21812 | 20 | 0.42 | Mlig455_019683 | Neo: - Age: - |
NMUR2 | 0.958 | - | - | - | - | - | 0.958 | Mlig455_019683 {REF} {Length: 2876} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=154.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=22.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=22.5]; Olfactory receptor [PF13853.8, score=21.0]} {Human: ENSG00000132911, NMUR2, neuromedin U receptor 2, [RH, Score=172, Expect=2e-48]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [RH, Score=173, Expect=4e-49]} {Dmel: FBgn0037100, CapaR, Capability receptor, [RH, Score=210, Expect=1e-62]} {Celegans: WBGene00019616, nmur-2, NMUR (NeuroMedin U Receptor) homolog, [RH, Score=209, Expect=4e-63]} {Smed: dd_Smed_v6_17801_0_1, dd_Smed_v6_17801_0_1, [RH, Score=257, Expect=1e-81]} {RNA1310_96825} |
| 23. | MligTC455_07699 | 36 | 0.75 | Mlig455_040321, Mlig455_050261 | Neo: - Age: - |
0.957 | - | - | - | - | - | 0.957 | Mlig455_040321 {REF} {Length: 2033} {TRANSSPLICED} {RNA1310_79439} {RNA815_63116} Mlig455_050261 {REF} {Length: 2510} {RNA1310_86895} {RNA815_64033} |
|
| 24. | MligTC455_47395 | 71 | 1.48 | Mlig455_052211 | Neo: - Age: - |
CHRNA10 | 0.955 | - | - | - | 0.955 | - | - | Mlig455_052211 {REF} {Length: 3367} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=210.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=144.4]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=125, Expect=9e-30]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=125, Expect=6e-30]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=120, Expect=4e-28]} {Dmel: FBgn0015519, nAChRalpha3, nicotinic Acetylcholine Receptor alpha3, [Score=111, Expect=9e-25]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=135, Expect=2e-33]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=123, Expect=3e-29]} {RNA1509_30974} {RNA1310_28768.1} {RNA815_26436} |
| 25. | MligTC455_24681 | 29 | 0.6 | Mlig455_015284 | Neo: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_015284 {REF} {Length: 3895} {RNA1509_34740} {RNA1310_6113.1} {RNA815_6593} |